• Ownership

Frank Karbe - Insider Trading & Ownership

Entity
Individual
Location
C/O Myovant Sciences Inc., 2000 Sierra Point Parkway, 9 Th Floor, Brisbane, CA
Summary
The estimated net worth of Frank Karbe is at least $7.13M dollars as of February 26, 2025. Frank Karbe is the Principal Fin'l & Accounting of Myovant Sciences Ltd. and owns shares of Myovant Sciences Ltd. stock worth about $5.73M. Frank Karbe is the Chief Financial Officer of Cidara Therapeutics, Inc. and owns shares of Cidara Therapeutics, Inc. (CDTX) stock worth about $857K. Frank Karbe is the Director of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $452K. Frank Karbe is the Chief Executive Officer, Director of Better Therapeutics, Inc. and owns shares of Better Therapeutics, Inc. (BTTX) stock worth about $89.5K.
All Insider Reports
All Insider Reports

Ownership of Frank Karbe

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MYOV Myovant Sciences Ltd. Principal Fin'l & Accounting $5.73M Jul 7, 2021
CDTX Cidara Therapeutics, Inc. Chief Financial Officer $857K Feb 24, 2025
PHAT Phathom Pharmaceuticals, Inc. Director $452K +$99.1K +28.1% Dec 13, 2024
BTTX Better Therapeutics, Inc. Chief Executive Officer, Director $89.5K Dec 18, 2023

Insider Transactions Reported by Frank Karbe:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.